Trial Profile
Safety and efficacy of direct antiviral agents in treatement of hepatitis C patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Dasabuvir (Primary) ; Ledipasvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2017 New trial record